pyridostigmine
Ligand Summary
A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.
UNII: 19QM69HH21
PubChem: 4991
PubChem: 91696191
Guide to Pharmacology: 8994
ChEMBL: CHEMBL1115
ChEMBL: CHEMBL812
DrugCentral: 2330
LyCHI: U2FK63XKTVJ7
Target Activities
9 Activities
Items per page:
1 – 9 of 9
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | INHIBITOR | |||||